Trefoil Peptides in Lung Diseases

Bispebjerg Hospital

Status: Completed

Conditions: Asthma; Chronic Obstructive Pulmonary Disease

Study type: Observational

Funder types: Other

Identifiers

NCT00839735

H-B-2008-120

Details and patient eligibility

About

The study focuses on trefoil family factor (TFF) peptides in sputum in lung diseases. The investigators hypothesize that TFF peptides are upregulated in lung diseases characterized by mucus hypersecretion.

Enrollment: 60 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Age 18 years or older
• Informed consent

Exclusion criteria

• Upper and lower airway infection 2 weeks prior to visit 1

Trial design

60 participants in 3 patient groups

COPD

Description:

Chronic obstructive pulmonary disease

Asthma

Healthy controls